Effect of age on in vitro triazolam biotransformation in male human liver microsomes

被引:25
作者
Patki, KC
von Moltke, LL
Harmatz, JS
Hesse, LM
Court, MH
Greenblatt, DJ
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Tufts New England Med Ctr, Div Clin Pharmacol, Boston, MA USA
关键词
D O I
10.1124/jpet.103.059311
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied age-related changes in enzyme kinetic parameters in human liver microsomes (HLMs) in vitro, using triazolam (TRZ), an index of CYP3A activity. HLMs were prepared from male livers from four age groups, n = 5 per group: A (14-20 years), B (21-40 years), C (41-60 years), and D (61-72 years). Mean V-max values in groups B and C for both 1-hydroxy-triazolam (1-OH-TRZ) and 4-hydroxy-triazolam (4-OH-TRZ) formation were significantly greater as compared with groups A and D individually, as well as the net intrinsic clearance (sum of the two pathways). The mean net intrinsic clearance (Cl-int) values were 25.2, 89.8, 78, and 20.6 nl/min/mg protein in A, B, C, and D, respectively. TRZ Cl-int correlated well with total CYP3A content (r(s) = 0.84; P < 0.0001). Testosterone (TST) inhibited 1-OH-TRZ formation and activated 4-OH-TRZ formation in all age groups, with no significant differences among the groups; this suggests that the drug-drug interaction potential using TRZ and TST as index CYP3A substrates may not change with age. Reduced V-max and Cl-int for TRZ hydroxylation and CYP3A protein in livers from elderly men suggest reduced CYP3A gene expression in this group.
引用
收藏
页码:874 / 879
页数:6
相关论文
共 40 条
  • [1] DESMETHYLDIAZEPAM KINETICS IN THE ELDERLY AFTER ORAL PRAZEPAM
    ALLEN, MD
    GREENBLATT, DJ
    HARMATZ, JS
    SHADER, RI
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 196 - 202
  • [2] BEAUNE PH, 1986, DRUG METAB DISPOS, V14, P437
  • [3] Bertz RJ, 1997, J PHARMACOL EXP THER, V281, P1317
  • [4] COTREAU MM, 2004, IN PRESS CLIN PHARMA
  • [5] AGE BUT NOT GENDER SELECTIVELY AFFECTS EXPRESSION OF INDIVIDUAL CYTOCHROME-P450 PROTEINS IN HUMAN LIVER
    GEORGE, J
    BYTH, K
    FARRELL, GC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (05) : 727 - 730
  • [6] GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
  • [7] PHARMACOKINETIC ASPECTS OF DRUG-THERAPY IN THE ELDERLY
    GREENBLATT, DJ
    ABERNETHY, DR
    SHADER, RI
    [J]. THERAPEUTIC DRUG MONITORING, 1986, 8 (03) : 249 - 255
  • [8] SENSITIVITY TO TRIAZOLAM IN THE ELDERLY
    GREENBLATT, DJ
    HARMATZ, JS
    SHAPIRO, L
    ENGELHARDT, N
    GOUTHRO, TA
    SHADER, RI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (24) : 1691 - 1698
  • [9] REDUCED CLEARANCE OF TRIAZOLAM IN OLD-AGE - RELATION TO ANTIPYRINE OXIDIZING CAPACITY
    GREENBLATT, DJ
    DIVOLL, M
    ABERNETHY, DR
    MOSCHITTO, LJ
    SMITH, RB
    SHADER, RI
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) : 303 - 309
  • [10] IMPLICATIONS OF ALTERED DRUG DISPOSITION IN THE ELDERLY - STUDIES OF BENZODIAZEPINES
    GREENBLATT, DJ
    SHADER, RI
    HARMATZ, JS
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (10) : 866 - 872